Zoetis (ZTS) Change in Cash (2012 - 2026)
Zoetis (ZTS) posted quarterly Change in Cash of -$509.0 million for Q1 2026, down 53.31% year-over-year from -$1.1 billion in Q1 2025, and down 323.25% quarter-over-quarter from $228.0 million in Q4 2025.
Zoetis (ZTS) Change in Cash (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Change in Cash for 15 consecutive years, with -$509.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 53.31% year-over-year to -$509.0 million; the TTM figure through Mar 2026 stood at $148.0 million (up 146.25% YoY), while the FY2025 annual figure was $325.0 million, up 701.85% from the prior year.
- Change in Cash fell to -$509.0 million in Q1 2026 per ZTS's latest filing, from $228.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $1.1 billion in Q4 2022 and bottomed at -$1.5 billion in Q1 2023.
- Historically, Change in Cash has averaged -$98.9 million across 5 years, with a median of -$145.0 million in 2022.
- On a YoY basis, Change in Cash climbed as much as 409.0% in 2022 and fell as far as 17400.0% in 2022.
- Zoetis' Change in Cash stood at $1.1 billion in 2022, then tumbled by 73.28% to $287.0 million in 2023, then declined by 4.88% to $273.0 million in 2024, then fell by 16.48% to $228.0 million in 2025, then slumped by 323.25% to -$509.0 million in 2026.
- Business Quant data shows ZTS's Change in Cash at -$509.0 million in Q1 2026, $228.0 million in Q4 2025, and $649.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 159.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -465.00 Mn |
| Mar 31, 2026 | -509.00 Mn |
| Dec 31, 2025 | 228.00 Mn |
| Sep 30, 2025 | 649.00 Mn |
| Jun 30, 2025 | -220.00 Mn |
| Mar 31, 2025 | -332.00 Mn |
| Dec 31, 2024 | 273.00 Mn |
| Sep 30, 2024 | 140.00 Mn |
| Jun 30, 2024 | -401.00 Mn |
| Mar 31, 2024 | -66.00 Mn |
| Dec 31, 2023 | 287.00 Mn |
| Sep 30, 2023 | 37.00 Mn |
| Jun 30, 2023 | -392.00 Mn |
| Mar 31, 2023 | -1.47 Bn |
| Dec 31, 2022 | 1.07 Bn |
| Sep 30, 2022 | -145.00 Mn |
| Jun 30, 2022 | -483.00 Mn |
| Mar 31, 2022 | -350.00 Mn |
| Dec 31, 2021 | 211.00 Mn |
| Sep 30, 2021 | -384.00 Mn |